Oncotelic Therapeutics Statistics
Total Valuation
OTLC has a market cap or net worth of 22.10 million. The enterprise value is 34.66 million.
| Market Cap | 22.10M |
| Enterprise Value | 34.66M |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OTLC has 434.93 million shares outstanding. The number of shares has increased by 5.07% in one year.
| Current Share Class | 434.93M |
| Shares Outstanding | 434.93M |
| Shares Change (YoY) | +5.07% |
| Shares Change (QoQ) | +11.14% |
| Owned by Insiders (%) | 46.07% |
| Owned by Institutions (%) | n/a |
| Float | 189.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.99 |
| P/TBV Ratio | 4.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.83 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01, with a Debt / Equity ratio of 1.83.
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | 1.83 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.34 |
Financial Efficiency
Return on equity (ROE) is -44.24% and return on invested capital (ROIC) is -0.77%.
| Return on Equity (ROE) | -44.24% |
| Return on Assets (ROA) | -0.62% |
| Return on Invested Capital (ROIC) | -0.77% |
| Return on Capital Employed (ROCE) | -3.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -151,011 |
| Employee Count | 26 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +145.75% in the last 52 weeks. The beta is -0.91, so OTLC's price volatility has been lower than the market average.
| Beta (5Y) | -0.91 |
| 52-Week Price Change | +145.75% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 52.23 |
| Average Volume (20 Days) | 81,443 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -279,276 |
| Pretax Income | -4.18M |
| Net Income | -3.93M |
| EBITDA | n/a |
| EBIT | -279,276 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 88,022 in cash and 13.55 million in debt, giving a net cash position of -13.46 million or -0.03 per share.
| Cash & Cash Equivalents | 88,022 |
| Total Debt | 13.55M |
| Net Cash | -13.46M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 7.39M |
| Book Value Per Share | 0.02 |
| Working Capital | -19.15M |
Cash Flow
| Operating Cash Flow | -540,184 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OTLC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.07% |
| Shareholder Yield | n/a |
| Earnings Yield | -17.76% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |